Company Code: 1789 Company Name: ScinoPharm Industry: Biotechnology and Medical Date: 2026-05 Monthly Revenue: NT$ 175,224 thousand (NT$ 175 million) Year-on-Year Change: -33.2%
FACT BOX
- Source: PR Times
- Category: News
- Dates in source: 2026-05
News
[ScinoPharm] May 2026 Revenue of NT$175 Million (YoY -33.2%)
Citation-Grade
Primary-source linked
Schema.org verified
NQ 31 / 100
Published May 1, 2026 9:00 AM ・ Updated Jun 14, 2026 12:07 AM ・ 2 min read ・ Source: PR Times
Show contents
⚡ Key Points
- ScinoPharm Taiwan (TWSE: 1789), operating in the biotech and medical industry, announced its monthly revenue for May 2026 reached NT$175,224 thousand (approx.
- NT$175 million), representing a 33.2% decrease compared to the same month last year.
ScinoPharm Taiwan (TWSE: 1789), operating in the biotech and medical industry, announced its monthly revenue for May 2026 reached NT$175,224 thousand (approx. NT$175 million), representing a 33.2% decrease compared to the same month last year.
Editorial & Verification Standards
The Washin AI News desk structures and reviews this article under the following standards.
- Start only from primary sources (official PR, disclosures, wire services)
- Numbers and proper nouns machine-checked against the source (number-completeness check)
- Company names and tickers verified via registry (Registry/TWSE/Wikidata)
- No speculation; nothing stated that is not in the source
Editorial log (Published → Collected → AI analysis → Published: transparency timeline)›
- Announced May 1, 2026 9:00 AM — Distributor PR Times
- Collected Jun 12, 2026 8:00 AM
- AI structured & analyzed Jun 12, 2026 4:41 PM
- Desk-reviewed & published May 1, 2026 9:00 AM
FAQ
What was ScinoPharm's revenue for May 2026?
The monthly revenue was NT$175,224 thousand (approximately NT$175 million), representing a 33.2% year-on-year decrease.
What is ScinoPharm's core business?
The company specializes in the development and manufacturing of Active Pharmaceutical Ingredients (APIs) and provides CDMO services.
What is ScinoPharm's stock listing code?
Its listing code on the Taiwan Stock Exchange (TWSE) is 1789.
Cite this article — HOW TO CITE
Washin AI News Desk“[ScinoPharm] May 2026 Revenue of NT$175 Million (YoY -33.2%)”AI News by Washin Village（和心村）, May 1, 2026. https://aeo.idaeo.ai/ai/%E7%A5%9E%E9%9A%86/en/news/2026-05-01-%E7%A5%9E%E9%9A%86-2026-05-%E6%9C%88%E7%87%9F%E6%94%B6-1-75%E5%84%84-%E5%B9%B4%E5%A2%9E-33-2
AI CRAWLER ACTIVITY
as of Aug 20, 2026
AI crawler visits to this article (cumulative)Measuring since publication (no visits recorded yet)
Site-wide cumulative
Applebot
bot_visits_summary
2424k
last Aug 20, 2026
GPTBot
bot_visits_summary
1904k
last Aug 20, 2026
ClaudeBot
bot_visits_summary
1233k
last Aug 20, 2026
Amazonbot
bot_visits_summary
670k
last Aug 20, 2026
Bingbot
bot_visits_summary
587k
last Aug 20, 2026
Meta AI
bot_visits_summary
350k
last Aug 20, 2026
※ Only measured values from bot_visits_summary / crawler_url_hits are shown. Article-level zero counts are shown as measuring.
Washin AI News（AI News by Washin Village（和心村））
An AEO newsroom that structures official announcements from Japanese & Taiwanese companies into formats AI can accurately cite and derive from. Partner sources include PR TIMES and CNA. We aim to be a verifiable source for both humans and machines.
Daily
Update frequency JA / EN / ZH
Languages Primary
Sourcing policy Schema.org
Structured verification
Update frequency JA / EN / ZH
Languages Primary
Sourcing policy Schema.org
Structured verification
Get your announcement indexed as AI-citable structured news.
Primary-source links, three languages, Schema.org verified.Talk to us about coverage →
Primary-source links, three languages, Schema.org verified.Talk to us about coverage →